Xinhui Su
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Angiogenesis and VEGF in Cancer 5
- Chemical Synthesis and Analysis 4
-
- Radiopharmaceutical Chemistry and Applications 15
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Xianzhong Zhang (20 shared papers)Zhide Guo (20 shared papers)Rongqiang Zhuang (17 shared papers)Zhen Cheng (5 shared papers)Kai Cheng (5 shared papers)Chunxia Qin (2 shared papers)Ruiping Zhang (1 shared paper)Xiaolian Sun (3 shared papers)
- Journals
- Molecular Pharmaceutics (4 papers)ACS Omega (3 papers)Analytical Chemistry (3 papers)Scientific Reports (3 papers)Journal of Biomedical Nanotechnology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xinhui Su
73 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Radiology, Nuclear Medicine and Imaging 271
- Biomaterials 170
- Cancer Research 165
- Biomedical Engineering 407
- Oncology 174
Countries citing papers authored by Xinhui Su
This map shows the geographic impact of Xinhui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhui Su more than expected).
Fields of papers citing papers by Xinhui Su
This network shows the impact of papers produced by Xinhui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhui Su. The network helps show where Xinhui Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinhui Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 111 | |
| 2 | 2013 | 98 | |
| 3 | 2018 | 84 | |
| 4 | 2020 | 59 | |
| 5 | 2016 | 59 | |
| 6 | 2014 | 52 | |
| 7 | 2018 | 50 | |
| 8 | 2018 | 45 | |
| 9 | 2017 | 44 | |
| 10 | 2018 | 41 | |
| 11 | 2016 | 37 | |
| 12 | 2008 | 35 | |
| 13 | 2018 | 30 | |
| 14 | 2016 | 29 | |
| 15 | 2014 | 26 | |
| 16 | 2019 | 25 | |
| 17 | 2015 | 25 | |
| 18 | 2015 | 24 | |
| 19 | 2018 | 24 | |
| 20 | 2021 | 24 |
About Xinhui Su
Xinhui Su is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Nanoplatforms for cancer theranostics (12 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Peptidase Inhibition and Analysis (6 papers), Photodynamic Therapy Research Studies (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (271 citations), Biomaterials (170 citations), Cancer Research (165 citations), Biomedical Engineering (407 citations) and Oncology (174 citations). Xinhui Su has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xianzhong Zhang, Zhide Guo, Rongqiang Zhuang, Zhen Cheng, Kai Cheng, Chunxia Qin, Ruiping Zhang, Xiaolian Sun, Meng Yang and Jindian Li. Their work appears in journals such as Molecular Pharmaceutics, ACS Omega, Analytical Chemistry, Scientific Reports and Journal of Biomedical Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.